Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Fenofibrate”

Showing 20 of 0 results

Not applicableStudy completedNCT02306889
What this trial is testing

Bioequivalence Study of Fenofibrate Capsules, 130 mg Under Fasting Conditions

Who this might be right for
Healthy
Ranbaxy Laboratories Limited 48
Post-approval studies (Phase 4)Study completedNCT00891293
What this trial is testing

A Second Open-Label Extension of a Double-Blind, Parallel, Phase IV Study to Assess the Efficacy and Safety of Adjunctive Lovaza® (Formerly Known as Omacor®) Therapy in Hypertriglyceridemic Subjects Treated With Antara™

Who this might be right for
Hypertriglyceridemia
GlaxoSmithKline 93
Post-approval studies (Phase 4)UnknownNCT00843661
What this trial is testing

Coadministration of Ezetimibe With Fenofibrate Versus Pravastatin Monotherapy for the Treatment of Hyperlipidaemia in HIV-infected Patients

Who this might be right for
HIVHyperlipidemiaHIV Infections
Ospedale di Circolo - Fondazione Macchi 60
Large-scale testing (Phase 3)UnknownNCT04882293
What this trial is testing

Efficacy and Safety of the Fixed-dose Combination Atorvastatin/Fenofibrate vs Atorvastatin in Patients With T2D and DLP.

Who this might be right for
Dyslipidemia Associated With Type II Diabetes Mellitus
Laboratorios Silanes S.A. de C.V. 78
Not applicableStudy completedNCT04885153
What this trial is testing

Effects of Oral Fenofibrate on Retinal Thickness and Macular Volume

Who this might be right for
Diabetic RetinopathyDyslipidemiasDiabetes Mellitus
Universitas Indonesia 36
Post-approval studies (Phase 4)UnknownNCT01010516
What this trial is testing

Comparison of High-Dose Rosuvastatin Versus Low Statin Dose Plus Fenofibrate Versus Low Statin Dose Plus Niacin in the Treatment of Mixed Hyperlipidemia

Who this might be right for
Dyslipidemia
University of Ioannina 120
Not applicableAvailableNCT00965315
What this trial is testing

Randomized Parallel-group Study to Investigate the Efficacy of a Combination of Rosuvastatin and Fenofibrate in the Patients With Diabetes or Atherosclerotic Vascular Diseases With Metabolic Syndrome

Who this might be right for
DiabetesCVD
National Taiwan University Hospital
Not applicableStudy completedNCT00299884
What this trial is testing

Atorvastatin Versus Ezetimibe and Fenofibrate as a Lipid-lowering Strategy

Who this might be right for
DyslipidemiaVascular Disease
Queen's University 45
Testing effectiveness (Phase 2)Study completedNCT00703755
What this trial is testing

A Randomized, Double-Blind Trial Comparing the Efficacy and Safety of Fenofibrate, Metformin, Their Combination and Placebo in Patients With Metabolic Syndrome.

Who this might be right for
Patients With Metabolic Syndrome
Solvay Pharmaceuticals 2,288
Testing effectiveness (Phase 2)Study completedNCT01594983
What this trial is testing

A Pilot Study to Assess the Efficacy and Safety of LCQ908 Alone and in Combination With Fenofibrate or Lovaza® in Patients With Severe Hypertriglyceridemia

Who this might be right for
Non Familial Chylocmicronemia Syndrome (Non-FCS)
Novartis Pharmaceuticals 58
Not applicableStudy completedNCT01280604
What this trial is testing

Effect of Fenofibrate Conversion on Triglyceride Levels in Patients on Statin Therapy

Who this might be right for
Hyperlipidemias
Kaiser Permanente 66
Not applicableStudy completedNCT01023750
What this trial is testing

Predictors of Response to Fenofibrate

Who this might be right for
HypertriglyceridemiaInsulin Resistance
University of Alabama at Birmingham 39
Not applicableEnded earlyNCT01289639
What this trial is testing

Insulin Resistance in Non-alcoholic Fatty Liver Disease

Who this might be right for
Fatty Liver
VA Office of Research and Development 11
Post-approval studies (Phase 4)Study completedNCT03615534
What this trial is testing

Extended Release Niacin and Fenofibrate for the Treatment of Atherogenic Dyslipidemia in Obese Females

Who this might be right for
Atherogenic DyslipidemiaObesity Associated Disorder
Lewai Sharki Abdulaziz, MSc PhD 161
Post-approval studies (Phase 4)Study completedNCT02886299
What this trial is testing

Randomized Comparative Efficacy and Safety Study of Intermittent Simvastatin and Fenofibrate in Hemodialysis

Who this might be right for
Fenofibrate/Simvastatin Comparison
Cairo University 60
Post-approval studies (Phase 4)Study completedNCT04528212
What this trial is testing

Fenofibrate Versus Curcumin in Type 2 Diabetic Patients

Who this might be right for
Diabetes Mellitus, Type 2
Rehab Werida 60
Testing effectiveness (Phase 2)Study completedNCT05781698
What this trial is testing

Repurposing Fenofibrate in Modulating mTOR/NLRP3 Inflammasome in Patients With Ulcerative Colitis

Who this might be right for
Inflammatory Bowel Diseases
Tanta University 60
Early research (Phase 1)Study completedNCT00961116
What this trial is testing

Bioequivalence Study of Fenofibric Acid Versus Tricor® (Fenofibrate)

Who this might be right for
Healthy
Mutual Pharmaceutical Company, Inc. 54
Testing effectiveness (Phase 2)Ended earlyNCT01142323
What this trial is testing

Pilot Study of Fenofibrate for PSC

Who this might be right for
Primary Sclerosing Cholangitis
University of Miami 8
Not applicableStudy completedNCT05542147
What this trial is testing

Genetic-Dependent Cardiovascular Response to PPAR-Alpha Agonist Fenofibrate

Who this might be right for
Type 2 DiabetesCardiovascular DiseasesPharmacogenomic Drug Interaction
Mario Luca Morieri 200
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation